EN
HI
Cohance Lifesciences Share price
COHANCE
987.3
3.40 (-0.34%)NSE
BSE
Last updated on 17 Sep, 2025 | 12:03 IST
BUYSELL
Today's High
996.00
Today's Low
983.80
52 Week Low
856.30
52 Week High
1360.00
The current prices are delayed, login to your account for live prices
LoginCohance Lifesciences Share Key Metrics
Volume
56557.00
Market Cap
37900.93 CR
LTQ@LTP
1@987.30
ATP
988.85
Var Margin
18.38 %
Circuit Range
792.6-1188.8
Delivery %
50.32 %
Value
5.59 CR
ASM/GSM
No
Market Lot
1
Cohance Lifesciences Corporate Actions
| Date | Agenda |
|---|---|
| 2025-08-13 | Quarterly Results |
| 2025-05-28 | Audited Results |
Cohance Lifesciences News
National Company Law Tribunal clears Casper Pharma’s merger with Suven Pharmaceuticals
Oct 30 2024 05:57:11
Read More
About Cohance Lifesciences
NSE : 17945
BSE : 543064
ISIN : INE03QK01018
Cohance Lifesciences Management
| Name | Position |
|---|---|
| Mr. Vivek Sharma | Executive Chairman |
| Dr. V Prasada Raju | Managing Director |
Cohance Lifesciences Similar Stocks
Glenmark Pharmaceuticals Ltd.
2058.90
-18.10 (0.87%)
Laurus Labs Ltd.
899.80
4.95 (0.55%)
Biocon Ltd.
359.25
-0.95 (0.26%)
Anthem Biosciences Ltd.
841.45
9.65 (1.16%)
Glaxosmithkline Pharmaceuticals Ltd.
2765.60
27.40 (1.00%)
Narayana Hrudayalaya Ltd.
1813.10
27.60 (1.55%)
Global Health Ltd.
1379.60
19.30 (1.42%)
Ipca Laboratories Ltd.
1313.10
1.60 (0.12%)
Gland Pharma Ltd.
1979.00
-42.80 (2.12%)
Aster DM Healthcare Ltd.
615.00
-4.90 (0.79%)
Cohance Lifesciences FAQs
The Buying Price of Cohance Lifesciences share is 987.3 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Cohance Lifesciences stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Cohance Lifesciences, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Cohance Lifesciences shares is 147.11. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Cohance Lifesciences shares is 21.66. Useful to assess the stock's value relative to its book value.
To assess Cohance Lifesciences’s valuation compare Sector P/E, P/B which are 33.3 & 3.74 with sector averages, along with growth rates and financial metrics.
The Market Cap of Cohance Lifesciences is 37900.93 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Cohance Lifesciences share price is 1360.00 & 856.30. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Cohance Lifesciences belongs to the Healthcare sector.